- Home
- ABEO vs FDBC Comparison
ABEO vs FDBC Comparison
Compare ABEO & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- FDBC
- Stock Information
- Founded
- ABEO N/A
- FDBC 1902
- Country
- ABEO United States
- FDBC United States
- Employees
- ABEO N/A
- FDBC N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- FDBC Major Banks
- Sector
- ABEO Health Care
- FDBC Finance
- Exchange
- ABEO Nasdaq
- FDBC Nasdaq
- Market Cap
- ABEO 277.6M
- FDBC 246.3M
- IPO Year
- ABEO 1980
- FDBC N/A
- Fundamental
- Price
- ABEO $6.27
- FDBC $50.03
- Analyst Decision
- ABEO Strong Buy
- FDBC
- Analyst Count
- ABEO 3
- FDBC 0
- Target Price
- ABEO $18.00
- FDBC N/A
- AVG Volume (30 Days)
- ABEO 289.4K
- FDBC 9.2K
- Earning Date
- ABEO 11-11-2024
- FDBC 10-23-2024
- Dividend Yield
- ABEO N/A
- FDBC 3.04%
- EPS Growth
- ABEO N/A
- FDBC N/A
- EPS
- ABEO N/A
- FDBC 2.75
- Revenue
- ABEO N/A
- FDBC $70,433,000.00
- Revenue This Year
- ABEO N/A
- FDBC N/A
- Revenue Next Year
- ABEO $7,097.06
- FDBC N/A
- P/E Ratio
- ABEO N/A
- FDBC $18.46
- Revenue Growth
- ABEO 147.52
- FDBC N/A
- 52 Week Low
- ABEO $3.05
- FDBC $41.10
- 52 Week High
- ABEO $9.01
- FDBC $60.85
- Technical
- Relative Strength Index (RSI)
- ABEO 56.31
- FDBC 51.53
- Support Level
- ABEO $6.39
- FDBC $47.31
- Resistance Level
- ABEO $6.74
- FDBC $50.68
- Average True Range (ATR)
- ABEO 0.30
- FDBC 1.06
- MACD
- ABEO -0.01
- FDBC 0.06
- Stochastic Oscillator
- ABEO 52.04
- FDBC 83.07
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers.